Oxford Biomedica plc (OTCMKTS:OXBDF) Short Interest Update

Oxford Biomedica plc (OTCMKTS:OXBDFGet Free Report) was the target of a significant growth in short interest during the month of February. As of February 28th, there was short interest totalling 78,300 shares, a growth of 131.0% from the February 13th total of 33,900 shares. Based on an average daily volume of 4,600 shares, the short-interest ratio is currently 17.0 days. Approximately 0.1% of the company’s shares are sold short.

Oxford Biomedica Price Performance

Shares of OTCMKTS:OXBDF opened at $3.53 on Friday. The company has a 50-day moving average price of $4.79 and a 200-day moving average price of $4.97. The company has a quick ratio of 2.07, a current ratio of 2.35 and a debt-to-equity ratio of 1.48. Oxford Biomedica has a 12 month low of $2.40 and a 12 month high of $5.68.

About Oxford Biomedica

(Get Free Report)

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.

Read More

Receive News & Ratings for Oxford Biomedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Biomedica and related companies with MarketBeat.com's FREE daily email newsletter.